Dyne Therapeutics, Inc. DYN Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s retained earnings?
- Dyne Therapeutics, Inc. (DYN) reported retained earnings of -$1.52B in Q1 2026.
- How has Dyne Therapeutics, Inc.'s retained earnings changed year-over-year?
- Dyne Therapeutics, Inc.'s retained earnings decreased by 42.4% year-over-year, from -$1.07B to -$1.52B.
- What is the long-term trend for Dyne Therapeutics, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s retained earnings has grown at a 77.5% compound annual growth rate (CAGR), from -$79.18M to -$1.4B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.